Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

被引：313

作者：

Powles, T. ^{[1
]}

Bellmunt, J. ^{[2
]}

Comperat, E. ^{[3
]}

De Santis, M. ^{[4
]}

Huddart, R. ^{[5
]}

Loriot, Y. ^{[6
,7
]}

Necchi, A. ^{[8
]}

Valderrama, B. P. ^{[9
]}

Ravaud, A. ^{[10
,11
]}

Shariat, S. F. ^{[12
]}

Szabados, B. ^{[1
,13
]}

van der Heijden, M. S. ^{[14
]}

Gillessen, S. ^{[15
]}

机构：

[1] Queen Mary Univ London, Barts Canc Ctr, Barts Hlth NHS Trust, London, England

[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, IMIM Lab, Boston, MA 02115 USA

[3] Hop Tenon, Assistance Publ Hop Paris, Paris, France

[4] Charite, Dept Urol, Berlin, Germany

[5] Royal Marsden Hosp, Inst Canc Res, London, England

[6] Univ Paris Saclay, Dept Med Oncol, Villejuif, France

[7] Gustave Roussy, Villejuif, France

[8] Univ Vita Salute San Raffaele, IRCCS San Raffaele Hosp, Dept Med Oncol, Milan, Italy

[9] Univ Hosp Virgen del Rocio, Seville, Spain

[10] Hop St Andre CHU, Bordeaux, France

[11] Bordeaux Univ Hosp, Dept Med Oncol, Bordeaux, France

[12] Med Univ Vienna, Vienna Gen Hosp, Dept Urol, Vienna, Austria

[13] Univ Coll London Hosp, Dept Urol, London, England

[14] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands

[15] EOC, Oncol Inst Southern Switzerland IOSI, Lugano, Switzerland

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 03期

关键词：

immune checkpoint inhibitors; fibroblast growth factor receptor inhibitors; antibody drug conjugates; bladder cancer; urothelial carcinoma; platinum-based chemotherapy; METASTATIC UROTHELIAL CARCINOMA; BACILLUS-CALMETTE-GUERIN; PHASE-III TRIAL; TRANSITIONAL-CELL CARCINOMA; COMBINED-MODALITY TREATMENT; RADICAL CYSTECTOMY; OPEN-LABEL; SINGLE-ARM; ADJUVANT CHEMOTHERAPY; PREDICTING RECURRENCE;

D O I：

10.1016/j.annonc.2021.11.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：244 / 258

页数：15

共 50 条

[31] Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Colombo, N.
Preti, E.
Landoni, F.
Carinelli, S.
Colombo, A.
Marini, C.
Sessa, C.
ANNALS OF ONCOLOGY, 2013, 24 : 33 - 38
[32] Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Glimelius, B.
Tiret, E.
Cervantes, A.
Arnold, D.
ANNALS OF ONCOLOGY, 2013, 24 : 81 - 88
[33] Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Parker, C.
Castro, E.
Fizazi, K.
Heidenreich, A.
Ost, P.
Procopio, G.
Tombal, B.
Gillessen, S.
ANNALS OF ONCOLOGY, 2020, 31 (09) : 1119 - 1134
[34] Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Eckel, F.
Brunner, T.
Jelic, S.
ANNALS OF ONCOLOGY, 2011, 22 : vi40 - vi44
[35] Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Smyth, E. C.
Verheij, M.
Allum, W.
Cunningham, D.
Cervantes, A.
Arnold, D.
ANNALS OF ONCOLOGY, 2016, 27 : v38 - v49
[36] Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Valle, J. W.
Borbath, I.
Khan, S. A.
Huguet, F.
Gruenberger, T.
Arnold, D.
ANNALS OF ONCOLOGY, 2016, 27 : v28 - v37
[37] Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Lordick, F.
Mariette, C.
Haustermans, K.
Obermannova, R.
Arnold, D.
ANNALS OF ONCOLOGY, 2016, 27 : v50 - v57
[38] Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Plataniotis, G.
Castiglione, M.
ANNALS OF ONCOLOGY, 2010, 21 : v41 - v45
[39] Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Okines, A.
Verheij, M.
Allum, W.
Cunningham, D.
Cervantes, A.
ANNALS OF ONCOLOGY, 2010, 21 : v50 - v54
[40] Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Eckel, F.
Brunner, T.
Jelic, S.
ANNALS OF ONCOLOGY, 2010, 21 : v65 - v69

← 1 2 3 4 5 →